Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...

CBSE has revamped its assessment pattern to include more case-based questions for Classes 10 and 12. This shift aims to ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...

Why treat people and send them back to the conditions that make them sick?”, one of us (Michael Marmot) has asked, based on overwhelming evidence that social forces are among the strongest ...

This article gives simple tips to help children study well during pollution-related online or hybrid classes. It explains how ...

Utilities are producing eye-popping forecasts about the amount of electricity they'll need to power massive new data centers that are feeding the fast-growing AI economy ABC News papal contributor ...

Pove was generally safe and well tolerated with adverse events (AEs) that were mostly mild or moderate in severity. There were no serious adverse events related to povetacicept. The safety data is ...

New! Sign up for our free email newsletter.